Skip to main content

Table 2 Univariate and multivariate logistic association for PC-AKI among the whole population

From: Effect of statins on post-contrast acute kidney injury: a multicenter retrospective observational study

 

Univariable Analysis

Multivariable Analysis

B

OR

95%CI

P

B

OR

95%CI

P

Male

−0.312

0.732

0.625–0.858

<0.001

− 0.397

0.672

0.558–0.809

<0.001

Age

0.025

1.025

1.018–1.033

<0.001

0.025

1.026

1.016–1.035

<0.001

Smoking

−0.201

0.818

0.66–1.014

0.067

0.003

1.003

0.771–1.304

0.984

Drinking

−0.292

0.746

0.593–0.939

0.013

−0.037

0.964

0.736–1.262

0.787

Hypertension

0.093

1.097

0.933–1.29

0.261

    

Diabetes

0.261

1.299

1.092–1.545

0.003

0.203

1.226

1.012–1.484

0.037

eGFR

−0.007

0.993

0.99–0.996

<0.001

0.003

1.003

0.998–1.007

0.209

Uric acid

0

1

0.999–1.001

0.928

    

LDL-C

−0.025

0.976

0.895–1.063

0.573

    

CRP

0.011

1.011

1.008–1.014

<0.001

0.009

1.009

1.006–1.012

<0.001

LVEF

−0.021

0.979

0.973–0.985

<0.001

−0.023

0.977

0.971–0.984

<0.001

Excess volumes of CM

0.479

1.614

1.15–2.266

0.006

0.55

1.733

1.156–2.596

0.008

Iso-osmolar CM

−0.001

0.999

0.846–1.179

0.988

    

Contrast Volume

0

1

0.999–1.001

0.557

    

Pre-operative statin therapy

− 0.53

0.589

0.488–0.711

<0.001

−0.554

0.575

0.466–0.709

<0.001

Prior myocardial infarction

0.163

1.177

0.925–1.497

0.185

    

Prior PCI

0.134

1.144

0.956–1.369

0.143

    

Prior CABG

−0.092

0.912

0.579–1.437

0.691

    

Prior cardiac surgery (except CABG)

−0.01

0.991

0.644–1.524

0.965

    

Angiography combined with PCI

0.054

1.055

0.904–1.232

0.496

    

 Multi vessel PCI

−0.003

0.997

0.789–1.258

0.977

    

 Total length of stents

−0.006

0.994

0.988–1

0.071

    
  1. Abbreviations: PC-AKI post-contrast acute kidney injury, eGFR estimated glomerular filtration rate, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, LVEF left ventricular ejection fractions, CM contrast medium, ACEI angiotensin converting enzyme inhibitors, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting